Oxiconazole
- Level
- Commodity
- Parent
- 51302300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51302323This classification denotes an antifungal agent with the molecular formula C18H13Cl4N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C668Q9I33J, chemically known as 1h-imidazole, 1-(2-((2-chloro-3-thienyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)- but generally known as oxiconazole, which bears US NIH Compound Identifier 5482. European Medicines Agency schedules Oxiconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09523MIG. The term OXICONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules oxiconazole in its Anatomical Therapeutic Chemical (ATC) Classification. OXICONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxiconazole under HS 29332990 and SITC 51573. As of Q4 2014, OXICONAZOLE remains the US FDA Preferred Term for this commodity. Oxiconazole bears US NLM identifiers UMLS ID C0069765 and NCI Concept Code C61869. SMILES: CLC1C(C(OCC2CCSC2CL)CN2CCNC2)CCC(CL)C1.
Same parent
Under 51302300 · 42Activities that produce or sell this
KBLI · 9Inherited from family 51300000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.